Smilesync
About
What does Smilesync do?
SmileSync provides an AI-first platform for dental practices, automating tasks such as clinical notes, treatment plans, consent forms, and patient communication. It also offers features for practice growth, including automated social media updates and performance insights. The platform aims to reduce administrative burden and improve patient engagement for dentists.
Is Smilesync trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Smilesync is 26 out of 100, based on site security posture and privacy practices.
Where is Smilesync headquartered?
Smilesync is headquartered in London, United Kingdom.
When was Smilesync founded?
Smilesync was founded in 2026.
What industry does Smilesync operate in?
Smilesync operates in Dental Tech, HealthTech, AI Agent, Practice Management Software, Workflow Automation, Voice AI.
Nidl provides an AI agent workforce for Canadian paramedical and dental clinics, automating administrative tasks like calls, scheduling, and billing.
Your everyday digital helping hand, bringing tasks, reminders, and smart devices together with personalized AI care.
An entrant is a company tagged Dental Tech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 2 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
Whether this company is a safe place to put your data: security posture, privacy signals, and reputation evidence we could verify.
Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.
No comments yet. Be the first to share your take.